Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Jun. 29, 2025	Jun. 30, 2024	Jun. 25, 2023
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Net income		$ 5,358,217	$ 3,827,772	$ 4,510,931
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		386,277	359,699	342,432
Deferred income taxes		(363,247)	(198,981)	(172,061)
Equity-based compensation expense		343,371	293,058	286,600
Other, net		6,845	10,243	52,298
Changes in operating asset and liability accounts:
Accounts receivable, net of allowance		(858,748)	303,443	1,452,256
Inventories		(180,733)	528,723	(961,968)
Prepaid expenses and other assets		(206,729)	(15,535)	136,016
Trade accounts payable		212,000	125,939	(522,200)
Deferred profit		1,147,759	(277,440)	163,467
Accrued expenses and other liabilities		328,252	(304,652)	(108,833)
Net cash provided by operating activities		6,173,264	4,652,269	5,178,938
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets		(759,186)	(396,670)	(501,568)
Business acquisitions, net of cash acquired		0	0	(119,955)
Proceeds from maturities of available-for-sale securities		0	34,336	91,295
Proceeds from sales of available-for-sale securities		0	3,430	6,837
Other, net		51,094	(11,710)	(11,171)
Net cash used for investing activities		(708,092)	(370,614)	(534,562)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs		(507,488)	(256,104)	(23,206)
Treasury stock purchases		(3,422,321)	(2,842,807)	(2,017,012)
Dividends paid		(1,149,542)	(1,018,915)	(907,907)
Reissuances of treasury stock related to employee stock purchase plan		140,113	119,966	109,899
Proceeds from issuance of common stock		2,452	15,553	11,111
Other, net		143	(13,543)	(3,552)
Net cash used for financing activities		(4,936,643)	(3,995,850)	(2,830,667)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		28,324	(22,374)	128
Net change in cash, cash equivalents and restricted cash		556,853	263,431	1,813,837
Cash, cash equivalents and restricted cash at beginning of year	[1]	5,850,803	5,587,372	3,773,535
Cash, cash equivalents and restricted cash at end of year	[1]	6,407,656	5,850,803	5,587,372
Schedule of non-cash transactions
Accrued payables for stock repurchases, including applicable excise tax		38,525	51,471	45,486
Accrued payables for capital expenditures		80,799	60,826	31,899
Dividends payable		291,981	260,905	231,267
Transfers of finished goods inventory to property and equipment		90,873	71,267	76,856
Supplemental disclosures:
Cash payments for interest		172,355	173,094	174,745
Cash payments for income taxes, net		972,513	991,821	809,748
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents		6,390,659	5,847,856	5,337,056
Restricted cash and cash equivalents	[1]	16,997	2,947	250,316
Total cash, cash equivalents, and restricted cash	[1]	$ 6,407,656	$ 5,850,803	$ 5,587,372

[1] Restricted cash is reported within Other assets in the Consolidated Balance Sheets